By Apoorva Mandavilli and Nathalia Holt
The “cell lines” used to develop monoclonal antibodies, as well as remdesivir and vaccines, began with fetal tissue decades ago.
Published: October 7, 2020 at 08:00PM
from NYT Health https://ift.tt/3iJyP8Q
via IFTTT
from WordPress https://ift.tt/2SCAIty
via IFTTT
No comments:
Post a Comment